Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirier, G.
Right arrow Articles by Lamoureux, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirier, G.
Right arrow Articles by Lamoureux, G.
NEUROLOGY 1987;37:693
© 1987 American Academy of Neurology

Clinical and Sleep laboratory study of narcoleptic symptoms in multiple sclerosis

G. Poirier, MSc, J. Montplaisir, MD, M. Dumont, MPs, P. Duquette, MD, F. Dbcary, MD, J. Pleines, MSc and G. Lamoureux, MD

Centre d'Étude du Sommeil (Mr. Poirier, Dr. Montplaisir, and Ms. Dumont), Hôpital du Sacré-Coeur, and the Hôpital Notre-Dame (Dr. Duquette and Ms. Pleines), Montréal, Québec; the Croix-Rouge Canadienne (Dr. Décary), Ottawa, Ontario; and the Institut Armand Frappier (Dr. Lamoureux), Laval, Queéec, Canada.

Seventy white patients with a diagnosis of MS and typed for their HLA-A, B, C, and DR were studied. A clinical interview and a questionnaire were used to evaluate the presence of narcoleptic symptoms. The prevalence of sleep attacks, cataplexy, and sleep paralysis was significantly elevated among these patients. However, no difference was seen between DR2 and non-DR2 subjects with regard to the incidence of narcoleptic symptoms. Nine DR2 patients complaining of both sleep attacks and cataplexy were studied in the sleep laboratory for five consecutive naps, but no polygraphic evidence of narcolepsy was found.

Address correspondence and reprint requests to Dr. Montplaisir, Centre d'Étude du Sommeil, Hôpital du Sacré-Coeur, 5400 Gouin Blvd, O., Montréal, Québec, H4J 1C5 Canada.

Received May 9, 1986. Accepted for publication in final form August 5, 1986.




This article has been cited by other articles:


Home page
Mult SclerHome page
S Knudsen, P. Jennum, K Korsholm, S. Sheikh, S Gammeltoft, and J. Frederiksen
Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis
Multiple Sclerosis, July 1, 2008; 14(6): 734 - 738.
[Abstract] [PDF]


Home page
J Child NeurolHome page
H. Kubota, T. Kanbayashi, Y. Tanabe, and Y. Kohno
A Case of Acute Disseminated Encephalomyelitis Presenting Hypersomnia With Decreased Hypocretin Level in Cerebrospinal Fluid
J Child Neurol, July 1, 2002; 17(7): 537 - 539.
[Abstract] [PDF]


Home page
NeurologyHome page
S. Malik, B. F. Boeve, L. E. Krahn, and M. H. Silber
Narcolepsy associated with other central nervous system disorders
Neurology, August 14, 2001; 57(3): 539 - 541.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.